Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus

Nutrition and Cancer

Volumn 50, Issue 2, 2004, Pages 168-173

  De Boer, Johan G ^a   Yang, Haiyan ^b   Holcroft, James ^c   Skov, Kirsten ^d  

^a UNIVERSITY OF VICTORIA   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALLYL SULFIDE; ELLAGIC ACID; GENOMIC DNA; N BENZYL N METHYLNITROSAMINE;

ALCOHOL CONSUMPTION; ANIMAL MODEL; ARTICLE; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA SEQUENCE; DRUG INHIBITION; ESOPHAGUS CANCER; FEEDING; GENE MUTATION; IN VIVO STUDY; LACTOSE OPERON; MALE; MUTAGENESIS; NONHUMAN; RAT; REPRESSOR GENE; RISK FACTOR; SEQUENCE ANALYSIS; TEA;

ALLYL COMPOUNDS; ANIMALS; ANTICARCINOGENIC AGENTS; DIMETHYLNITROSAMINE; ELLAGIC ACID; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; MALE; MUTATION; RATS; RATS, INBRED F344; SULFIDES; TEA;

ANIMALIA;

EID: 12744274888     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5002_6     Document Type: Article

References (53)

1. World Health Organization: The World Health Report: Conquering Suffering, Enriching Humanity, Geneva: World Health Organization, 1997.
2. Schottenfeld D: Epidemiology of cancer of the esophagus. Semin Oncol 11, 92-100, 1984.
3. Fennerty MB and Triadafilopoulos G: Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option? Am J Gastroenterol 96, 2302-2305, 2001.
4. Beer DG and Stoner GD: Clinical models of chemoprevention for the esophagus. Hematol Oncol Clin North Am 12, 1055-1077, 1998.
5. Hodgson RM, Schweinsberg F, Wiessler M, and Kleihues P: Mechanism of esophageal tumor induction in rats by N-nitrosomethylbenzylamine and its ring-methylated analog N-nitrosomethyl(4-methylbenzyl)amine. Cancer Res 42, 2836-2840, 1982.
6. Tricker AR, Wacker CD, and Preussmann R: Nitrosation products from the plant Ephedra altissima and their potential endogenous formation. Cancer Lett 35, 199-206, 1987.
7. Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, et al.: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61, 6112-6119, 2001.
8. Ludeke BI, Domine F, Ohgaki H, and Kleihues P: Modulation of N-nitrosomethylbenzylamine bioactivation by diallyl sulfide in vivo. Carcinogenesis 13, 2467-2470, 1992.
9. Ushida J, Sugie S, Kawabata K, Pham QV, Tanaka T, et al.: Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res 91, 893-898, 2000.
10. Stoner GD and Morse MA: Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett 114, 113-119, 1997.
11. Khanduja KL, Gandhi RK, Pathania V, and Syal N: Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37, 313-318, 1999.
12. Dixit R and Gold B: Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid. Proc Natl Acad Sci USA 83, 8039-8043, 1986.
13. Terwel L and van der Hoeven JC: Antimutagenic activity of some naturally occurring compounds towards cigarette-smoke condensate and benzo[a]pyrene in the Salmonella/microsome assay. Mutat Res 152, 1-4, 1985.
14. Skov K, Adomat H, Hutcheon J, de Boer JG, and Yang H: Studies on the chemopreventive action of ellagic acid (EA) in vitro, and on its in vivo protection against NMBA-induced esophageal mutagenesis (abstract). AACR Frontiers in Cancer Prevention Research, Boston, MA: American Association for Cancer Research, 2004.
15. Katiyar SK, Agarwal R, Zaim MT, and Mukhtar H: Protection against N-nitrosodiethylamine and benzo[a]pyrene- induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14, 849-855, 1993.
16. Fujita Y, Yamane T, Tanaka M, Kuwata K, Okuzumi J, et al.: Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum. Jpn J Cancer Res 80, 503-505, 1989.
17. Jiang T, Glickman BW, and de Boer JG: Protective effect of green tea against benzo[a]pyrene-induced mutations in the liver of Big Blue transgenic rats. Mutat Res 480-481, 147-151, 2001.
18. Shukla Y, Arora A, and Singh A: Antitumorigenic potential of diallyl sulfide in Ehrlich ascites tumor bearing mice. Biomed Environ Sci 15, 41-47, 2002.
19. Guyonnet D, Belloir C, Suschetet M, Siess MH, and Le Bon AM: Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic. Carcinogenesis 23, 1335-1341, 2002.
20. Wargovich MJ, Woods C, Eng VW, Stephens LC, and Gray K: Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res 48, 6872-6875, 1988.
21. Bosetti C, La Vecchia C, Negri E, and Franceschi S: Wine and other types of alcoholic beverages and the risk of esophageal cancer. Eur J Clin Nutr 54, 918-920, 2000.
22. Young RR, Rogers BJ, Provost GS, Short JM, and Putman DL: Interlaboratory comparison: liver spontaneous mutant frequency from lambda/laci transgenic mice (BigBlue) (II). Mutat Res 327, 67-73, 1995.
23. Erfle HL, Walsh DF, Holcroft J, Hague N, de Boer JG, et al.: An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals. Environ Mol Mutagen 28, 393-396, 1996.
24. Carr J and Gorelick N: Statistical tests of significance in transgenic mutation assay: considerations on the experimental unit. Environ Mol Mutagen 24, 276-282, 1994.
25. de Boer JG, Mirsalis JC, and Glickman BW: Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice. Environ Mol Mutagen 34, 80-83, 1999.
26. Siglin JC, Khare L, and Stoner GD: Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats. Carcinogenesis 16, 259-265, 1995.
27. Glickman BW, Horsfall MJ, Gordon AJ, and Burns PA: Nearest neighbor affects G:C to A:T transitions induced by alkylating agents. Environ Health Perspect 76, 29-32, 1987.
28. Yang CS: Research on esophageal cancer in China: a review. Cancer Res 40, 2633-2644, 1980.
29. Hodgson RM, Wiessler M, and Kleihues P: Preferential methylation of target organ DNA by the oesophageal carcinogen N-nitrosomethylbenzylamine. Carcinogenesis 1, 861-866, 1980.
30. Gopalakrishnan R, Morse MA, Lu J, Weghorst CM, Sabourin CL, et al.: Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. Carcinogenesis 20, 885-891, 1999.
31. Pinto LF, Moraes E, Albano RM, Silva MC, Godoy W, et al.: Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis. Carcinogenesis 22, 1877-1883, 2001.
32. Wang D, Weghorst CM, Calvert RJ, and Stoner GD: Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N- nitrosomethylbenzylamine. Carcinogenesis 17, 625-630, 1996.
33. Lozano JC, Nakazawa H, Cros MP, Cabral R, and Yamasaki H: G→A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol Carcinog 9, 33-39, 1994.
34. Liston BW, Gupta A, Nines R, Carlton PS, Kresty LA, et al.: Incidence and effects of Ha-ras codon 12 G→A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus. Mol Carcinog 32, 1-8, 2001.
35. Wang X, Suzuki T, Itoh T, Honma M, Nishikawa A, et al.: Specific mutational spectrum of dimethylnitrosamine in the lacI transgene of Big Blue C57BL/6 mice. Mutagenesis 13, 625-630, 1998.
36. Horsfall MJ and Glickman BW: Mutation site specificity of N-nitroso-N-methyl-N-alpha-acetoxybenzylamine: a model derivative of an esophageal carcinogen. Carcinogenesis 9, 1529-1532, 1988.
37. Burns PA, Gordon AJE, and Glickman BW: Influence of neighbouring base sequence on N-methyl-N′-nitro-N-nitrosoguanidine mutagenesis in the lacI gene of Escherichia coli. J Mol Biol 194, 385-390, 1987.
38. Torronen R, Hakkinen S, Karenlampi S, and Mykkanen H: Flavonoids and phenolic acids in selected berries. Cancer Lett 114, 191-192, 1997.
39. Stohr H and Herrmann K: [V. The phenolics of strawberries and their changes during development and ripeness of the fruits (author's transl)]. Z Lebensm Unters Forsch 158, 341-348, 1975.
40. Mandal S and Stoner GD: Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11, 55-61, 1990.
41. Narayanan BA, Geoffroy O, Willingham MC, Re GG, and Nixon DW: p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136, 215-221, 1999.
42. Shepherd AG, Manson MM, Ball HW, and McLellan LI: Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia. Carcinogenesis 21, 1827-1834, 2000.
43. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, and Hollenberg PF: The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 17, 821-828, 1996.
44. Barch DH, Rundhaugen LM, and Pillay NS: Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene. Carcinogenesis 16, 665-668, 1995.
45. Barch DH, Rundhaugen LM, Stoner GD, Pillay NS, and Rosche WA: Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis 17, 265-269, 1996.
46. Barch DH and Fox CC: Selective inhibition of methylbenzylnitrosamine- induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats. Cancer Res 48, 7088-7092, 1988.
47. Vogel EW, Nivard MJ, Ballering LA, Bartsch H, Barbin A, et al.: DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation. Mutat Res 353, 177-218, 1996.
48. Morse MA, Kresty LA, Steele VE, Kelloff GJ, Boone CW, et al.: Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis. Nutr Cancer 29, 7-12, 1997.
49. Muto S, Fujita K, Yamazaki Y, and Kamataki T: Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 479, 197-206, 2001.
50. Morse MA, Lu J, Stoner GD, Murphy SE, and Peterson LA: Metabolism of N-nitrosobenzylmethylamine by human cytochrome P-450 enzymes. J Toxicol Environ Health A 58, 397-411, 1999.
51. Morris CR, Chen SC, Zhou L, Schopfer LM, Ding X, et al.: Inhibition by allyl Sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and rat CYP2A3. Nutr Cancer 48, 54-63, 2004.
52. Kaneko M, Morimura K, Nishikawa T, Wanibuchi H, Osugi H, et al.: Weak enhancing effects of simultaneous ethanol administration on chemically induced rat esophageal tumorigenesis. Oncol Rep 9, 1069-1073, 2002.
53. Mori Y, Koide A, Kobayashi Y, Morimura K, Kaneko M, and Fukushima S: Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver. Mutagenesis 17, 251-256, 2002.